Product Information
MORPHINE SULF ER 200 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $2.1267 per EA under NDC 63304045301. Its NADAC has been published 474 times since Dec 9, 2015.
FDA first approved this application on May 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304045301
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA078761FDA Approved
5/11/2012
TE Code
AB
On Market Since
5/11/2012
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULF ER 200 MG TABLET has been published 474 times since Dec 9, 2015, and over the history we have for it it has declined 48.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1267 per EA |
|---|---|
| All-time high | $4.9101 (Jan 13, 2016) |
| All-time low | $1.6606 (Jun 19, 2024) |
| 52-week high | $2.3835 |
| 52-week low | $1.9746 |
| Median price | $2.5441 |
| Average price | $2.6624 |
| Largest weekly change | +62.5% (Feb 19, 2020) |
| Weeks tracked | 474 |
| Tracking since | Dec 9, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the morphine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
morphine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULF ER 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF ER 200 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $2.1267 per EA (NDC 63304045301), effective Sep 30, 2026.
How has the price of MORPHINE SULF ER 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for MORPHINE SULF ER 200 MG TABLET has declined 48.3%. It has been tracked across 474 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for MORPHINE SULF ER 200 MG TABLET?
Since Dec 9, 2015, the NADAC for MORPHINE SULF ER 200 MG TABLET has ranged from a low of $1.6606 (Jun 19, 2024) to a high of $4.9101 (Jan 13, 2016), with a median of $2.5441 per EA.
Are there cheaper alternatives to MORPHINE SULF ER 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULF ER 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULF ER 200 MG TABLET?
MORPHINE SULF ER 200 MG TABLET (NDC 63304045301) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.